structural basis action diverse antidepressants biogenic amine transporters 
biogenic amine transporters bats regulate endogenous neurotransmitter concentrations targets broad range therapeutic agents including selective serotonin reuptake inhibitors ssris serotonin-noradrenaline reuptake inhibitors snris tricyclic antidepressants tcas eukaryotic bats recalcitrant crystallographic analysis understanding mechanism inhibitors antidepressants limited leut bacterial homologue bats proven valuable paradigm understanding relationships structure function however approximately % amino acid sequence leut common bats leut promiscuous amino acid transporter recapitulate pharmacological properties bats indeed ssris tcas bind extracellular vestibule leut- act non-competitive inhibitors transport contrast multiple studies demonstrate tcas ssris competitive inhibitors eukaryotic bats bind primary binding pocket- engineered leut harbour human bat-like pharmacology mutating key residues around primary binding pocket final leubat mutant binds ssri sertraline binding constant nm displays high-affinity binding range ssris snris tca determined crystal structures leubat complex four classes antidepressants chemically diverse inhibitors remarkably similar mode binding straddle transmembrane helix tm wedge tm3/tm8 tm1/tm6 lock transporter sodium-and chloride-bound outward-facing open conformation together studies define common simple principles action ssris snris tcas bats 
